SLN

#3393
Silence Therapeutics Plc American Depository Share
6.12 USD
+1.83%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
6.12
6.12
Rango anual
2.63
7.91
Cambio diario
+1.83%
Variación mensual
-18.40%
Variación en los últimos 6 meses
+3.90%
Cambio anual
+119.35%
Cierres anteriores
6.01
Abrir
6.12
Bid
Ask
Mínimo
6.12
High
6.12
Volumen
41
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 289.07 M
  • Employee 88
  • Founded 1994
  • CEO Craig A Tooman
  • Website www.silence-therapeutics.com
  • Headquarter United Kingdom
  • FIGI BBG00WVTHPN2
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-9.65
Relación precio/flujo de caja
1 541.15

Silence Therapeutics Plc - American Depository Share

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Noticias